FRANK KING: Open Payments
NPI 1447218052 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,343 in 104 payments from 17 companies in 2025. Trend: 2023 $2,809 · 2024 $2,816 · 2025 $2,343
Food & beverage: $2,309Education: $34
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $484 |
| Boston Scientific Corporation | 16 | $367 |
| VERTEX PHARMACEUTICALS INCORPORATED | 8 | $231 |
| Curonix LLC | 11 | $202 |
| Ipsen Biopharmaceuticals, Inc | 7 | $174 |
| Collegium Pharmaceutical, Inc. | 10 | $170 |
| Merz Pharmaceuticals, LLC | 5 | $153 |
| Medtronic, Inc. | 7 | $150 |
| TerSera Therapeutics LLC | 5 | $123 |
| BIOTISSUE HOLDINGS INC. | 1 | $117 |
Products named: WaveWriter Alpha Prime 16, QULIPTA, JOURNAVX, PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A, BOTOX, Dysport, Belbuca, Xeomin.
Industry payments across CA — which companies pay providers there.
